---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270175610.md"
description: "Athira Pharma shares are trading higher after the company announced it has entered into an agreement to acquire the rights for the development and commercialization of lasofoxifene."
datetime: "2025-12-18T14:15:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270175610.md)
  - [en](https://longbridge.com/en/news/270175610.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270175610.md)
generator: "portal-rs"
---

# 

Athira Pharma shares are trading higher after the company announced it has entered into an agreement to acquire the rights for the development and commercialization of lasofoxifene.

### Related Stocks

- [ATHA.US](https://longbridge.com/en/quote/ATHA.US.md)

## Related News & Research

- [Short Interest in Leonardo S.P.A. - Unsponsored ADR (OTCMKTS:FINMY) Decreases By 60.6%](https://longbridge.com/en/news/278693644.md)
- [Mizuho Cuts Athira Pharma (NASDAQ:LONA) Price Target to $15.00](https://longbridge.com/en/news/296388056.md)
- [Athira Pharma (NASDAQ:LONA) Price Target Lowered to $17.00 at Citizens Jmp](https://longbridge.com/en/news/296112345.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**